Literature DB >> 25192048

Histopathologic features of intracranial vascular involvement in fibromuscular dysplasia, ehlers-danlos type IV, and neurofibromatosis I.

Seth Lummus1, Robert Breeze, M Scott Lucia, Bette Kay Kleinschmidt-DeMasters.   

Abstract

Nonatherosclerotic cerebrovascular arteriopathies share epidemiologic and clinical features, but few studies directly compare histologic features of the intracranial vasculature. We studied 3 adult autopsy cases of fibromuscular dysplasia in patients who died of basilar artery aneurysm rupture, vertebral artery dissection, or Moyamoya syndrome. Fibromuscular dysplasia was only identified when multiple sections (optimally of the entire circle of Willis) were examined by microscopy. A fourth case of a massive subcutaneous scalp cirsoid aneurysm with classic "string-of-beads" gross appearance and microscopic medial hypertrophy was also compatible with fibromuscular dysplasia. Intracranial vascular changes were compared with those in 1 patient with Ehlers-Danlos type IV (vascular type) and in 4 patients with neurofibromatosis I. Distinct histologic features and distributions of cerebral vessel abnormalities were observed in all 3 disorders. Disordered collagen within the muscularis (identified using picrosirius red histochemistry) was confined to fibromuscular dysplasia; fibrocellular smooth muscle intimal proliferation within parenchymal cerebral arteries was confirmed using smooth muscle actin immunohistochemistry in the Moyamoya case; the patient with Ehlers-Danlos type IV showed aneurysm formation and eccentric intimal thickening of circle of Willis vessels but no obvious abnormalities of the muscularis; and neurofibromatosis I cases showed extensive leptomeningeal smaller-caliber arterial disease that particularly affected the spinal cord. Thus, cranial/intracranial artery involvement is not rare in these conditions but requires extensive sampling to identify the range of features.

Entities:  

Mesh:

Year:  2014        PMID: 25192048     DOI: 10.1097/NEN.0000000000000113

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  7 in total

Review 1.  An update on the central nervous system manifestations of neurofibromatosis type 1.

Authors:  J Stephen Nix; Jaishri Blakeley; Fausto J Rodriguez
Journal:  Acta Neuropathol       Date:  2019-04-08       Impact factor: 17.088

2.  Case Report of a Hemangioblastoma With Large Blood Vessels and Rare Vascular Anomalies: Is It Fibromuscular Dysplasia or Arteriovenous Malformation Association?

Authors:  Luis A Rodríguez-Hernández; Marcos V Sangrador-Deitos; Humberto Montano-Tello; Michel Mondragon-Soto; Martha Lilia L Tena Suck
Journal:  Cureus       Date:  2022-04-27

3.  Safety Assessment of Endovascular Treatment of Cerebral Aneurysms in Patients with Fibromuscular Dysplasia.

Authors:  Matthew T Bender; Christopher Hurtado; Bowen Jiang; Jessica K Campos; Judy Huang; Rafael J Tamargo; Li-Mei Lin; Alexander L Coon; Geoffrey P Colby
Journal:  Interv Neurol       Date:  2017-12-16

Review 4.  A Review of the Genetics of Intracranial Berry Aneurysms and Implications for Genetic Counseling.

Authors:  Emma Hitchcock; William T Gibson
Journal:  J Genet Couns       Date:  2016-10-14       Impact factor: 2.537

5.  NF2 deficiency accelerates neointima hyperplasia following vascular injury via promoting YAP-TEAD1 interaction in vascular smooth muscle cells.

Authors:  Xiongshan Sun; Shuang Li; Xueqing Gan; Ken Chen; Dachun Yang; Yongjian Yang
Journal:  Aging (Albany NY)       Date:  2020-05-18       Impact factor: 5.682

Review 6.  The complex genetic basis of fibromuscular dysplasia, a systemic arteriopathy associated with multiple forms of cardiovascular disease.

Authors:  Adrien Georges; Nabila Bouatia-Naji
Journal:  Clin Sci (Lond)       Date:  2022-08-31       Impact factor: 6.876

7.  The defining pathology of the new clinical and histopathologic entity ACTA2-related cerebrovascular disease.

Authors:  Maria-Magdalena Georgescu; Marco da Cunha Pinho; Timothy E Richardson; Jose Torrealba; L Maximilian Buja; Dianna M Milewicz; Jack M Raisanen; Dennis K Burns
Journal:  Acta Neuropathol Commun       Date:  2015-12-04       Impact factor: 7.801

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.